Since Jeme and Nordin (10) and Ingraham and Bussard (9) described the plaque method for enumerating the number of plaque-forming cells (PFC) to sheep red blood cells (SRBC), the technique has been used for studies on the cellular level of the mechanism of antibody production. Thereafter, Cunningham and Szenberg (2) modified this technique, and many other reports described the use of this method for detecting PFC to various antigens, e.g., bacterial polysaccharide, lipopolysaccharide, heterologous proteins, synthetic compounds, and viruses (1, 7, 8, 11-13, 15-17, 19, 21, 23, 24 ; B. H. Peterson and J. S. Ingraham, Fed. Proc. 26:641, 1967 ).
This method of localized hemolysis has been employed for the detection of antibodies, both 19S and 7S, to a number of antigens, but it has been rarely applied to antibody production in tuberculous infection. One could expect that PFC would be found in draining sites from antibody-forming tissues of tuberculous infection, however, since the sera of tuberculous human beings or animals contain antibodies as detected by the Middlebrook-Dubos or Boyden reaction. In fact, Parlett and Chu (18) were able to measure PFC in suspensions of spleen cells from H37Ra-infected rabbits and from BCG-infected mice, respectively. This paper is concerned with detection of PFC in cells of the regional lymph node, its efferent lymph, and the spleen of rabbits, in the primary and secondary response to BCG bacilli. The results indicated that the cell suspension from these tissues had many PFC specific to the tuberculoprotein antigen and that the time course of PFC appearance was the same as that in sensitization to SRBC.
MATERIALS AND METHODS
Immunization. (i) Primary infection. BCG suspension (strain from National Institute of Health, Tokyo) (0.4 ml of 20 mg [wet weight] of cells/ml; 8 X 107 viable cells) was injected into each hind footpad of rabbits weighing over 2 kg. Cells were obtained from the popliteal lymph nodes, efferent lymph from those nodes, spleens, peritoneal exudates, and pulmonary washings at 3, 5, 7, 10, 13, 19 and 26 days after infection, and examined for PFC. Five animals were sacrificed on each day.
(ii) Secondary infection. Eight weeks after the primary infection, the same injections were repeated. Cells were obtained 1 day before the reinjection and 1, 3, 5 and 7 days after it. Three animals were examined on each day. Efferent lymphatic cells. Efferent lymph from the popliteal lymph node was collected by the method of Ehrich and Harris (5). Rabbits were fixed in the supine position with the legs widely separated. Under anesthesia with Nembutal, the skin of the inner side of the knee and the semitendinosus and semimembranosus muscles were cut, and the popliteal lymph node was exposed. The efferent lymph vessel of the lymph node was ligated, and the feet were exercised to drive the lymph upward to the efferent lymph vessel. Lymph was collected through a 27-gauge needle into a "tuberculin" syringe containing 0.1 ml of heparinized (5 Plaque formation. PFC were assayed by the method of Jerne and Nordin (10) . Glass petri dishes (6-cm diameter) were partially filled with a 3-ml layer (designated as the underlayer) of 1.4% melted agar in Earle solution. The agar was allowed to harden, and the plates were stored at 4 C until needed. To perform the test, 1.4% agar in distilled water was melted and kept at 47 C. To this solution was added Ho volume of 10 X concentrated Earle solution and diethylaminoethyl-dextran to the final concentration of 0.85 mg/ml for reducing anticomplementary effects of the agar. A 10-ml amount of the agar-Earle solution was added to 1 ml of 33% TPt-coated SRBC suspension. A 1-ml amount of this agar-RBC suspension was mixed with 0.6 ml of appropriate concentrations of the cell suspensions. One milliliter of this mixture was poured over the previously prepared underlayer of agar and evenly distributed, and then, 1 ml of the 1:10 dilution of normal guinea pig serum was poured on top after the agar had hardened. After incubation at 37 C for 1 hr, the plates were washed once gently with PBS. The number of clear, round plaques was counted by using a projector. Usually assays were done in triplicate, and the test cell concentration was adjusted so as to produce 50 to 100 plaques per plate.
RESULTS
Plaque formation with two antigen preparations from the culture filtrate of tubercle bacilli. The effectiveness in coating SRBC for lysis by antibody was compared for the following preparations: (i) TPt, precipitated by trichloroacetic acid from nonheated H37Rv culture filtrates; (ii) tuberculin polysaccharide (TPs-80), precipitated by 80% saturation of methanol from the culture filtrates after first removing TPt, as described above, and the polysaccharide precipitable at 40% saturation of methanol.
SRBC (33% suspension) were sensitized with each antigen at 1, 25, 50, and 75 mg/ml for tests of the plaque-forming capacity of lymph node cells obtained 5 days after the secondary injection of BCG (Table 1) . At 1 mg/ml concentration, only a small number of plaques was produced, and the number of plaques increased with concentration of antigen. However, the TPt antigen at 75 mg/ml caused considerable hemolysis of SRBC during the sensitizing procedure. On the other hand, with the TPs-80 antigen the plaque number was maximal at the 25 mg/ml concentration and decreased with lower or higher concentrations. The maximal plaque number obtained with TPt was about twice that with the TPs-80 antigen. TPt antigen at 50 mg/ml was therefore used for sensitization of SRBC throughout the following experiments. As control, the inhibition test on the plate containing 1 mg of TPt per ml or 500 ,ug of TPs-80 per ml showed 88 to 97% inhibition of plaque formation using TPt-coated or TPs-80-coated SRBC, but plaque formation was not inhibited with 500,ug of protein per ml precipitated from a culture filtrate of Aspergillus fumigatus.
Kinetics of PFC during immune response: primary infection. The number of PFC produced by cells of the popliteal lymph node, efferent lymph, and the spleen on given days after primary infection of BCG are shown in Fig. 1 . The PFC of efferent lymphatic cells showed two peaks 3 and 10 days after infection, attaining a maximal number of 106 PFC/106 nucleated cells. The cells in the secondary response were large as in the primary response, reached the maximal size at 3 days and showed many blast cells. The lymph contained polymorphonuclear leukocytes in small number at the first and third day (Table  5) .
DISCUSSION
Jerne and Nordin (10) described PFC in agar, using the regional lymph node and spleen cells from mice sensitized with SRBC. One plaque was attributed to hemolysis caused by a single antibody-producing cell. This plaque-forming technique for antibody-forming cells has increased our knowledge about the mechanism of antibody formation at the cellular level. The antibody detected by this method was of 19S class, and the plaques increased in parallel with the serum 19S antibody level (15, 17) . Dresser and Wortis (4) The present study further demonstrated the (14) showed a maximum at 10 to 17 days after immunization with viable BCG. In the present study, the number of PFC reached a maximum at 5 days in the lymph node and at 7 days in the spleen. These results are more similar to those in the case of sensitization with SRBC. On the other hand, maintenance of the high level of PFC in the lymph node cells during a relatively long period of 5 to 10 days, in the present study, and the appearance of the second peak at 10 days in the efferent lymphatic cells and at 13 days in the spleen cells might be due to the use of viable bacilli, BCG, which can proliferate in the injected animals.
In the secondary response, the numbers of PFC in the lymph node, its efferent lymph, and the spleen increased abruptly at 3 days and decreased rapidly thereafter. Probably this high number at 3 days was the sum of newly produced PFC and of restimulation of primed cells by booster injection. Parlett and Chu (18) recognized no anamnestic response of PFC production in tuberculous animals after a booster injection. However, the present study confirmed an enhanced response, as described by Larson et al. (14) . It is likely that immature forms (blast cells) distributed into antibody-producing tissues through efferent lymph vessels from the regional lymph node are able to respond to the secondary stimulation as memory cells.
The rapid decrease of PFC at 5 days may be the result of the inhibition by early high production of 7S antibody in the secondary response as suggested by David and Pearlman (3) , Sahiar and Schwartz (20) , and Finkelstein and Uhr (6) . At 3 days, the regional lymph nodes release actively many mature antibody-producing cells, as well as blast cells, through lymph vessel to the whole body.
Individual plaque size on one plate was not uniform, especially in the later stage. Appearance of the large plaques was not correlated with an increase in numbers of PFC. The increase of the plaque size could depend on some factors which have been described: low concentration of SRBC in the reaction system (10), lower affinity of the antibody produced to target red cells, or less efficient coupling of SRBC by antigen (19) . In the present study, however, these factors can hardly be considered to operate as cause of influencing the plaque size, because large plaques 
